There was an increase in soluble IL1RL1 levels in the gut, which was mainly associated with the active state of ulcerative colitis, indicating a possible negative regulation of the IL1RL1/IL33 pathway in order to dampen the inflammation. The gene discussed is IL1RL1; the disease is ulcerative colitis.